Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.57 |
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | GAA | P10253 | 2/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | GLA | P06280 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 4/20 | 0.57 |
| ▸ | RAB9A | P51151 | 4/20 | 0.57 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | CASP1 | P29466 | 1/20 | 0.52 |
| ▸ | CASP7 | P55210 | 1/20 | 0.52 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6419717 | 0.99 | ALDH1A1 (0.59) | ALDH1A1KDM4ELMNAGAAL3MBTL1 | |
| SCHEMBL12569032 | 0.87 | HSD17B3 (0.49) | ALDH1A1MAPTMEN1KMT2APOLB | |
| SCHEMBL15803999 | 0.85 | ALDH1A1 (0.67) | ALDH1A1KDM4ELMNAGAAL3MBTL1 | |
| SCHEMBL13942802 | 0.84 | ALDH1A1 (0.65) | ALDH1A1KDM4ELMNAGAAL3MBTL1 | |
| SCHEMBL12887317 | 0.82 | ALDH1A1 (0.68) | ALDH1A1KDM4ELMNAGAAL3MBTL1 | |
| SCHEMBL21151718 | 0.82 | HSD17B3 (0.47) | ALDH1A1KDM4ELMNAGAAL3MBTL1 | |
| SCHEMBL8571801 | 0.81 | ALDH1A1 (0.66) | ALDH1A1KDM4ELMNAGAAL3MBTL1 | |
| SCHEMBL23859828 | 0.81 | HPGD (0.73) | ALDH1A1LMNAL3MBTL1MAPTNPC1 | |
| SCHEMBL3183371 | 0.81 | HPGD (0.73) | ALDH1A1LMNAL3MBTL1MAPTNPC1 | |
| SCHEMBL8972518 | 0.81 | HPGD (0.73) | ALDH1A1LMNAL3MBTL1MAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140027746-A1 | STAR-SHAPED COMPOUNDS FOR ORGANIC SOLAR CELLS | HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) | 2014-01-30 | — | — | US | disclosed |
| US-20140027746-A1 | STAR-SHAPED COMPOUNDS FOR ORGANIC SOLAR CELLS | HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) | 2014-01-30 | — | — | US | disclosed |
| EP-2668224-A1 | STAR-SHAPED COMPOUNDS FOR ORGANIC SOLAR CELLS | Heraeus Precious Metals GmbH & Co. KG (DE) | 2013-12-04 | — | — | EP | disclosed |
| WO-2012100908-A1 | STAR-SHAPED COMPOUNDS FOR ORGANIC SOLAR CELLS | HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) | 2012-08-02 | — | — | WO | disclosed |
| US-20110101318-A1 | NOVEL MACROMOLECULAR COMPOUNDS HAVING A CORE-SHELL STRUCTURE FOR USE AS SEMICONDUCTORS | HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) | 2011-05-05 | — | — | US | disclosed |
| US-20110101318-A1 | NOVEL MACROMOLECULAR COMPOUNDS HAVING A CORE-SHELL STRUCTURE FOR USE AS SEMICONDUCTORS | HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) | 2011-05-05 | — | — | US | disclosed |
| US-20110101318-A1 | NOVEL MACROMOLECULAR COMPOUNDS HAVING A CORE-SHELL STRUCTURE FOR USE AS SEMICONDUCTORS | HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) | 2011-05-05 | — | — | US | disclosed |
| WO-2009112319-A1 | NOVEL MACROMOLECULAR COMPOUNDS HAVING A CORE-SHELL STRUCTURE FOR USE AS SEMICONDUCTORS | H.C. STARCK GMBH (DE) | 2009-09-17 | — | — | WO | disclosed |
| EP-1007035-A4 | POLYTHIOPHENE ANTI-TUMOR AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2000-11-22 | — | — | EP | disclosed |
| EP-1007035-A1 | POLYTHIOPHENE ANTI-TUMOR AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2000-06-14 | — | — | EP | disclosed |
| WO-1998023269-A1 | POLYTHIOPHENE ANTI-TUMOR AGENTS | PURDUE RESEARCH FOUNDATION (US) | 1998-06-04 | — | — | WO | disclosed |
| US-5753692-A | PLANT EXTRACTS, IMMUNOSTIMULANTS TREATING IMMUNODEFICIENCY DISEASES | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 1998-05-19 | — | — | US | disclosed |
| US-5747525-A | ANTITUMOR AGENTS OF OLIGOMERS OF THIOPHENE | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 1998-05-05 | — | — | US | disclosed |
| US-5741811-A | ADMINISTERING TO CANCER PATIENTS | PURDUE RESEARCH FOUNDATION (US) | 1998-04-21 | — | — | US | disclosed |
| US-5602170-A | ADMINISTERING ANTIIFLAMMATORY AGENT | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 1997-02-11 | — | — | US | disclosed |
| US-5578636-A | Polythiophene anti-tumor agents | PURDUE RESEARCH FOUNDATION (US) | 1996-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110101318-A1 | NOVEL MACROMOLECULAR COMPOUNDS HAVING A CORE-SHELL STRUCTURE FOR USE AS SEMICONDUCTORS | EPCAM, MRPS22, ILK | ALDH1A1 4398/4885KDM4E 3316/4885LMNA 3876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.